Clincosm LogoSign in Get a demo

major depressive disorder

Showing NaN - NaN of 113
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDD Trial in Australia, Puerto Rico, United States (ALKS 5461, ALKS 5461 Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • ALKS 5461
  • ALKS 5461 Placebo
  • Tucson, Arizona
  • +34 more
Mar 15, 2021

MDD Trial in United States (Vortioxetine, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • Phoenix, Arizona
  • +78 more
Dec 16, 2020

MDD Trial in Puerto Rico, United States (AGO178)

Terminated
  • Major Depressive Disorder
  • Birmingham, Alabama
  • +97 more
Dec 16, 2020

MDD Trial in Puerto Rico, United States (Agomelatine (AGO178C), Placebo)

Completed
  • Major Depressive Disorder
  • Agomelatine (AGO178C)
  • Placebo
  • Birmingham, Alabama
  • +44 more
Dec 16, 2020

MDD Trial in Puerto Rico, United States (agomelatine, )

Completed
  • Major Depressive Disorder
  • Scottsdale, Arizona
  • +43 more
Dec 15, 2020

MDD Trial in United States (agomelatine, )

Completed
  • Major Depressive Disorder
  • Birmingham, Alabama
  • +77 more
Dec 15, 2020

MDD Trial in Puerto Rico, United States (Agomelatine (AGO178C), Placebo)

Completed
  • Major Depressive Disorder
  • Agomelatine (AGO178C)
  • Placebo
  • Birmingham, Alabama
  • +47 more
Dec 15, 2020

MDD Trial in Worldwide (MIN-117 5.0 mg, MIN-117 2.5 mg, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • MIN-117 5.0 mg
  • +2 more
  • Little Rock, Arkansas
  • +46 more
Dec 14, 2020

MDD Trial in Puerto Rico, United States (Placebo, Levomilnacipran, Fluoxetine)

Completed
Has Results
  • Major Depressive Disorder
  • Placebo
  • +2 more
  • Dothan, Alabama
  • +48 more
Aug 19, 2020

MDD Trial in United States (TS-121 10 mg, TS-121 50 mg, Placebo)

Terminated
Has Results
  • Major Depressive Disorder
  • TS-121 10 mg
  • +2 more
  • Little Rock, Arkansas
  • +21 more
Jul 1, 2020

MDD Trial in United States (Placebo, Ketamine)

Completed
Has Results
  • Major Depressive Disorder
  • Birmingham, Alabama
  • +12 more
May 18, 2020

MDD Trial in United States (Esketamine, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • Birmingham, Alabama
  • +13 more
May 7, 2020

Depression, MDD Trial in Canada, United States (Levomilnacipran ER, Placebo)

Completed
Has Results
  • Depression
  • Major Depressive Disorder
  • Levomilnacipran ER
  • Placebo
  • Beverly Hills, California
  • +34 more
Dec 23, 2019

MDD Trial in United States (Placebo, Vilazodone)

Completed
Has Results
  • Major Depressive Disorder
  • Imperial, California
  • +51 more
Dec 6, 2019

MDD Trial in Atlanta (Video Task, Imaginal Task)

Completed
  • Major Depressive Disorder
  • Video Task
  • Imaginal Task
  • Atlanta, Georgia
  • +2 more
Sep 18, 2019

MDD Trial in Canada, United States (Vilazodone)

Completed
Has Results
  • Major Depressive Disorder
  • Birmingham, Alabama
  • +55 more
Sep 10, 2019

MDD Trial in Puerto Rico, United States (Cariprazine, Antidepressant Therapy (ADT))

Completed
Has Results
  • Major Depressive Disorder
  • Tucson, Arizona
  • +89 more
Jul 29, 2019

MDD Trial in Canada, United States (ALKS 5461)

Completed
Has Results
  • Major Depressive Disorder
  • ALKS 5461
  • Jacksonville, Florida
  • +8 more
Aug 2, 2019

MDD Trial in Bulgaria, United States (ALKS 5461, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • ALKS 5461
  • Placebo
  • Little Rock, Arkansas
  • +57 more
May 31, 2019

MDD Trial in United States (ALKS 5461, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • ALKS 5461
  • Placebo
  • Tucson, Arizona
  • +26 more
Apr 26, 2019

MDD Trial in United States (Antidepressant + , Antidepressant + cariprazine (0.1-0.3 mg/day), Antidepressant + cariprazine (1-2

Completed
Has Results
  • Major Depressive Disorder
  • Antidepressant + placebo
  • +2 more
  • Phoenix, Arizona
  • +40 more
Feb 12, 2019

Depression, MDD, MDD Trial in Atlanta, Augusta (suvorexant, Placebo)

Unknown status
  • Depression
  • +3 more
  • Atlanta, Georgia
  • +1 more
Feb 25, 2019

MDD Trial in Mexico, United States (desvenlafaxine succinate sustained release, fluoxetine, )

Completed
Has Results
  • Major Depressive Disorder
  • desvenlafaxine succinate sustained release
  • +2 more
  • Dothan, Alabama
  • +42 more
Jan 2, 2019

MDD Trial in Worldwide (ALKS 5461)

Completed
Has Results
  • Major Depressive Disorder
  • ALKS 5461
  • Birmingham, Alabama
  • +157 more
Nov 21, 2018

MDD, Anxiety Disorder, Obsessive Compulsive Disorder Trial in Atlanta (Two-Week Antidepressant Taper Regimen, One-Week

Terminated
Has Results
  • Major Depressive Disorder
  • +3 more
  • Two-Week Antidepressant Taper Regimen
  • One-Week Antidepressant Taper Regimen
  • Atlanta, Georgia
  • +2 more
Sep 21, 2018